428 Participants Needed

Intracranial Pressure Monitoring for Pediatric Traumatic Brain Injury

(BELA TRIPP Trial)

Recruiting at 12 trial locations
RM
KC
Overseen ByKelley Chaddock, BA
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Washington
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 4 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores the best treatment for severe traumatic brain injury (TBI) in children by comparing two methods. One group receives treatment guided by intracranial pressure (ICP) monitoring, which checks the pressure inside the skull. The other group follows a protocol based on imaging and physical exams without invasive monitoring. The goal is to determine if one approach aids recovery better than the other. Suitable candidates for this trial are children aged 1-12 who have suffered a severe non-penetrating head injury and are admitted to the hospital within 24 hours of the injury. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could improve future treatment strategies for children with severe TBI.

Will I have to stop taking my current medications?

The trial information does not specify whether participants must stop taking their current medications.

What prior data suggests that intracranial pressure monitoring is safe for pediatric traumatic brain injury?

Research has shown that monitoring pressure inside the skull can be safely conducted in children with severe head injuries. One study performed this procedure without causing additional harm, but it did not lower the risk of death or the need for further brain surgeries. Another study found that while this monitoring might increase survival rates, it did not improve long-term recovery. For example, some children scored lower on a test measuring everyday skills six months after treatment. Although generally well-tolerated, this monitoring has not clearly demonstrated benefits in reducing serious complications from head injuries.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores two different approaches to managing severe traumatic brain injury in children. One approach uses invasive intracranial pressure (ICP) monitoring, which is guided by the Brain Trauma Foundation Guidelines, to provide precise measurements of pressure inside the skull. This can help tailor treatment to prevent further brain injury. The other approach, known as the CREVICE protocol, avoids invasive monitoring and relies on imaging and clinical examination for decision-making. By comparing these two methods, researchers hope to determine the most effective way to manage pediatric traumatic brain injuries, potentially improving outcomes and reducing risks associated with invasive procedures.

What evidence suggests that intracranial pressure monitoring is effective for pediatric traumatic brain injury?

This trial will compare two approaches for managing pediatric severe traumatic brain injury. One arm will use a protocol based on invasive intracranial pressure (ICP) monitoring, while the other will follow the CREVICE protocol, which does not involve ICP monitoring. Research has shown mixed results regarding the effectiveness of monitoring pressure inside the skull in treating children with serious brain injuries. Some studies suggest that while this monitoring can increase survival rates, it might not lead to better long-term recovery. For example, one study found that monitoring improved survival rates but didn't necessarily enhance long-term recovery. Another review noted that monitoring might not reduce in-hospital deaths, possibly due to the severity of the injuries. Overall, the evidence on the impact of this monitoring remains unclear, with results varying based on different factors.12678

Who Is on the Research Team?

RC

Randall Chesnut, MD

Principal Investigator

University of Washington

Are You a Good Fit for This Trial?

This trial is for children aged 1-12 who have suffered a non-penetrating traumatic brain injury (TBI) and are admitted to the hospital within 24 hours of the incident. They must have a severe TBI, indicated by a low score on the Glasgow Coma Scale (GCS), and consent from parents or guardians. Children with injuries suspected to be caused intentionally or those with certain unresponsive pupil conditions cannot participate.

Inclusion Criteria

Provision of signed and dated informed consent form by the parent(s) or guardian(s)
Total GCS score ≤ 8 on admission or within first 48 hours after injury (measured using pediatric GCS 1 for children < 2 years old and standard GCS for older children)
I have had a traumatic brain injury that did not penetrate the skull.
See 3 more

Exclusion Criteria

I am in a deep coma with no eye response.
Motor GCS score of 6
Injury thought to be intentionally inflicted by a family member or caregiver.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive treatment for severe traumatic brain injury guided by either ICP monitoring or imaging and clinical examination protocols

1 month
Inpatient ICU stay

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessments of quality of life and functional outcomes

6 months
Assessments at 3 and 6 months post-injury

What Are the Treatments Tested in This Trial?

Interventions

  • CREVICE
  • ICP
Trial Overview The study compares two ways of treating severe pediatric TBI: one uses invasive monitoring of pressure inside the skull (ICP), while the other follows treatment protocols without such monitoring. The goal is to see which method leads to better recovery outcomes for these young patients.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: No ICP Monitoring Protocol CREVICEActive Control1 Intervention
Group II: ICP monitoring based ProtocolActive Control1 Intervention

ICP is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Intracranial Pressure Monitoring for:
🇺🇸
Approved in United States as Intracranial Pressure Monitoring for:
🇨🇦
Approved in Canada as Intracranial Pressure Monitoring for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Washington

Lead Sponsor

Trials
1,858
Recruited
2,023,000+

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Trials
2,103
Recruited
2,760,000+

Published Research Related to This Trial

Transcranial Doppler and optic nerve sheath diameter assessments are identified as the most effective noninvasive methods for monitoring intracranial pressure (ICP) in pediatric traumatic brain injury (TBI), based on a review of 27 studies.
While invasive ICP monitoring remains the gold standard, the noninvasive techniques offer promising advantages such as high sensitivity and diagnostic accuracy, potentially making them the future of neurointensive care for children with TBI.
Noninvasive Intracranial Pressure Monitoring for Severe Traumatic Brain Injury in Children: A Concise Update on Current Methods.Narayan, V., Mohammed, N., Savardekar, AR., et al.[2018]
Increased intracranial pressure (ICP) is linked to poorer outcomes following traumatic brain injury (TBI), making ICP monitoring crucial for treatment decisions, especially in severe cases.
Current guidelines emphasize maintaining cerebral perfusion pressure and managing elevated ICP, with monitoring being a standard practice in developed countries for pediatric TBI.
Management of raised intracranial pressure in children with traumatic brain injury.Kukreti, V., Mohseni-Bod, H., Drake, J.[2020]
In a study of 98 children with severe head injuries, fiberoptic intracranial pressure (ICP) monitoring was found to be safe and effective, with no complications during device insertion and a low infection rate (7% positive cultures) despite prolonged monitoring.
The study reported a 13% mechanical failure rate of the fiberoptic device, but overall, the monitoring technique showed minimal risk of complications and was effective in managing severe head injuries.
Risk factors of intracranial pressure monitoring in children with fiberoptic devices: a critical review.Jensen, RL., Hahn, YS., Ciro, E.[2019]

Citations

Effects of intracranial pressure monitoring in pediatric ...This meta-analysis found no overall reduction in in-hospital mortality with ICP monitoring in pediatric severe TBI, potentially due to baseline severity ...
The Path From Intracranial Pressure to Clinical Outcomes ...Current pediatric guidelines recommend bolus 3% HTS to rapidly reduce ICP and improve cerebral perfusion pressure (CPP).
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/28846763/
Functional Outcome After Intracranial Pressure Monitoring for ...Overall, 484 children (15.7%) experienced the primary composite outcome. A propensity approach using matching weights generated good covariate ...
Predicting intracranial pressure monitor placement in children ...Variation in intracranial pressure monitoring and outcomes in pediatric traumatic brain injury . Arch Pediatr Adolesc Med . 2012. ;. 166. : 641.
1575: icp monitoring improves mortality but not functional ...Patients who received ICP monitoring were more likely to have subarachnoid (47.7% vs. 26.8%, p< 0.001) and subdural hemorrhage (39.6% vs. 28.5%, ...
Intracranial Pressure Monitoring and 6-Month Outcomes of ...Patients who underwent ICP monitoring had a worse Glasgow Outcome Scale–Extended score at 6 months than the matched, nonmonitored control patients.
Monitoring and Measurement of Intracranial Pressure in ...ICP monitoring in pediatric TBI relates to the 10% who suffer a moderate or severe head trauma with a higher risk of intracranial complications (60).
Intracranial Pressure Monitoring in Children with Severe ...In this study, ICP monitoring was safely conducted in children with severe TBI. However, monitoring did not reduce the incidence of death, cranial surgeries, ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security